RetaNord sells research peptides exclusively to qualified researchers and laboratories for in vitro and laboratory use. Please confirm before continuing.
By proceeding you affirm the statements above are true. Products are not for human or veterinary use and have not been evaluated by the European Medicines Agency or any other regulatory authority.

Combination research blend
GLOW is a combination research blend of three widely studied peptides — GHK-Cu, BPC-157 and TB-500 — presented together in a single vial for skin, connective-tissue and recovery research.
Both kit sizes ship within the EU — free shipping either way.
Plain, unbranded packaging. No product names, no logos — nothing on the outside indicating what is inside. Tracked to a DPD Locker or your address.
Guaranteed delivery. If your order doesn't reach you, we ship it again free — lost, damaged or stolen.
For laboratory and in vitro research use only. Not for human or veterinary use, and not for use in diagnostic procedures.
GLOW combines three of the most-studied research peptides — the copper tripeptide GHK-Cu, the pentadecapeptide BPC-157, and the thymosin β4 fragment TB-500 — in one lyophilized vial. The blend is studied together in the context of skin, connective-tissue and recovery research. The mg figure is the combined peptide mass per vial.
RetaNord supplies GLOW as fixed kits of 10 or 30 lyophilized vials, each verified at 99%+ identity purity by independent third-party HPLC (Janoshik), and every kit ships with a lot-specific Certificate of Analysis. Supplied for laboratory and in vitro research use only.
GLOW puts three separately studied peptides in one vial, each working through a different mechanism. GHK-Cu is a copper-carrying tripeptide described in the literature as a modulator of gene expression in skin. BPC-157 is a 15–amino-acid sequence associated with angiogenic and growth-factor signalling. TB-500 is the actin-binding fragment of thymosin β4, which regulates the actin available for cell migration.
The rationale in the literature is that skin and connective-tissue repair involves copper availability, new vessel formation and cell migration at once — three processes, three molecules. Note that the published work studies these peptides individually; the blend itself is not a studied entity.
Mechanistic summary drawn from published literature, provided for research context only. Not a therapeutic claim.
Each constituent has its own literature: GHK-Cu in skin gene-expression work, BPC-157 in wound healing, and thymosin β4 in actin regulation. The references below are for the individual peptides.
There is no published trial of the three-peptide combination as such. Anyone stating otherwise is overreaching. All three are preclinical research compounds, not approved medicines.
An educational summary of published literature. It is not a claim about any outcome for any buyer, and RetaNord supplies this compound for laboratory research use only.
Sealed, lyophilized vials. 2–8 °C for routine storage; −20 °C or below for long-term. Room temperature is for transit and handling only — it is not a storage state for a peptide.
Once reconstituted. Keep at 2–8 °C and never freeze — ice crystals cause irreversible damage. Reconstituted with bacteriostatic water (0.9% benzyl alcohol) a vial is commonly used within about 30 days; with plain sterile water, within 24–48 hours.
Keep vials sealed and protected from light, and minimise freeze–thaw cycles of frozen stock — each cycle costs potency.
Work out concentration and draw volume in the reconstitution calculator →
| Category | Skin & Recovery |
|---|---|
| Compound class | Research blend — GHK-Cu + BPC-157 + TB-500 |
| Presentation | 10 vials per kit · lyophilized |
| Available sizes | 50 · 70 mg per vial |
| Constituent peptides | GHK-Cu + BPC-157 + TB-500 · combined peptide mass per vial |
| Physical form | Sterile-filtered, freeze-dried |
| Identity purity | 99%+ (HPLC) |
| Independent testing | Janoshik · third-party HPLC |
| Storage | 2–8°C; −20°C long term |
| Documentation | Lot-specific Certificate of Analysis |
Certificate of Analysis — batch VT725553Independent third-party testing by Janoshik · HPLC purity 99.432% and content verified.View the full report →Selected peer-reviewed literature via PubMed, provided for educational context. A reference does not imply a clinical claim for RetaNord products.
Yes — every kit ships with a lot-specific third-party Certificate of Analysis: independent HPLC purity and content testing by Janoshik, with the batch matching your vials. View the current CoA.
GLOW is a fixed combination of GHK-Cu, BPC-157 and TB-500. The size (50 or 70 mg) refers to the total combined peptide mass in each vial. Supplied for laboratory research use only.
These research compounds are supplied in fixed kits of 10 identical vials — the standard research quantity. One kit (10 vials) is the minimum order to the EU.
Sealed lyophilized vials keep at 2–8 °C, or −20 °C for long-term storage. Once reconstituted, keep refrigerated and never freeze it. See storage & handling for the full detail.
The volume of bacteriostatic water you add sets the concentration — the vial size alone does not. Enter your vial size and diluent volume in the reconstitution calculator to calculate the concentration for your assay.
Just the individual peptides. GHK-Cu, BPC-157 and thymosin β4 each have their own published literature; there is no published trial of the three-peptide combination as a single entity. The references below are for the constituents.
Every RetaNord kit ships within 24–48 hours, discreetly packaged and tracked. All kits ship within the EU. For laboratory research use only.
Order this kitA person answers every message — the same day, seven days a week.